Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for prevention of postoperative nausea and vomiting after outpatient gynecologic laparoscopic surgery
IRCT20241002063239N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Pregabalin with Placebo (2 arms). Primary endpoints: Incidence of nausea and vomiting, Severity of nausea and vomiting and 1 more. Started Apr 2025; status: completed.
02
Drugs
pregabalin
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20241002063239N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241002063239N1.